An Open-label, Single Centre Study, to Determine the Safety and Efficacy of Body Lotion and Body Wash in Adult Female Subjects with Mild To Moderate Eczema.

Wipro Manufacturing Services Sdn Bhd0 个研究点目标入组 22 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1. Age: 18 to 65 years (both inclusive) old healthy, non-pregnant, and non-lactating female at the time of consent.
•2. Females who have childbearing potential should have a negative urine pregnancy test at the time of the screening visit.
•3. Mild to Moderate Eczema determined by Eczema Area and Severity Index (EASI) score on screening visit. [Subjects with moderate erythema (Redness: score 2) and mild scratch mark (Scratching: score 1) will be enrolled in the study].
•4. Subjects with at least two active lesions on feet/face/hands or any part of the body.
•5. Subjects have only a few or no pigmentation on the selected test site.
•6. The subjectÃ¢â?¬•s in general good health as determined by Investigator based on medical history.
•7. Subjects must agree to refrain from shower/bath or generally wet their skin within 3 hours before scheduled study visits.
•8. Subjects must agree to wear loose clothing to allow easy exposure to the entire body during study visits.
•9. Subjects must be able to understand and provide written informed consent to participate in the study.
•10. Subjects should be willing and able to follow the study protocol to participate in the study.

发起方